Home Cart Sign in  
Chemical Structure| 2154406-04-7 Chemical Structure| 2154406-04-7

Structure of Zandatrigine
CAS No.: 2154406-04-7

Chemical Structure| 2154406-04-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Zandatrigine (NBI-921352) is a sodium channel protein type 8 subunit α blocker. It is used in neurological research, specifically for the treatment of epilepsy.

Synonyms: NBI-921352; XEN901

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Zandatrigine

CAS No. :2154406-04-7
Formula : C22H25FN4O2S2
M.W : 460.59
SMILES Code : CN([C@@H]1CN(CC1)CC2=CC=CC=C2)C3=C(C=C(C(F)=C3)S(NC4=CSC=N4)(=O)=O)C
Synonyms :
NBI-921352; XEN901
MDL No. :MFCD34676688

Safety of Zandatrigine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05493293 Focal Onset Seizure|Focal Onse... More >>t Epilepsy Less << PHASE2 TERMINATED 2024-03-11 Neurocrine Clinical Site, Fitz... More >>roy, 3065, Australia|Neurocrine Clinical Site, Heidelberg, 3084, Australia|Neurocrine Clinical Site, Melbourne, 3004, Australia|Neurocrine Clinical Site, Bruxelles, 1070, Belgium|Neurocrine Clinical Site, Ghent, 9000, Belgium|Neurocrine Clinical Site, Leuven, 3000, Belgium|Neurocrine Clinical Site, Brno, 65691, Czechia|Neurocrine Clinical Site, Ostrava, 708 52, Czechia|Neurocrine Clinical Site, Prague, 15006, Czechia|Neurocrine Clinical Site, Praha 6, 16000, Czechia|Neurocrine Clinical Site, Praha 8, 18600, Czechia|Neurocrine Clinical Site, Rychnov Nad Kně?nou, 51601, Czechia|Neurocrine Clinical Site, Bron, 69677, France|Neurocrine Clinical Site, Lille, 59037, France|Neurocrine Clinical Site, Rennes, 35000, France|Neurocrine Clinical Site, Toulouse, 31059, France|Neurocrine Clinical Site, Budapest, 1145, Hungary|Neurocrine Clinical Site, Budapest, 40320, Hungary|Neurocrine Clinical Site, Pecs, 7623, Hungary|Neurocrine Clinical Site, Bologna, 40139, Italy|Neurocrine Clinical Site, Milano, 20133, Italy|Neurocrine Clinical Site, Pavia, 27100, Italy|Neurocrine Clinical Site, Barcelona, 8035, Spain|Neurocrine Clinical Site, Madrid, 28034, Spain|Neurocrine Clinical Site, Madrid, 28040, Spain|Neurocrine Clinical Site, Valencia, 46026, Spain Less <<
NCT05226780 SCN8A Developmental and Epilep... More >>tic Encephalopathy Syndrome Less << PHASE2 ENROLLING_BY_INVITATION 2025-03-26 UCSF Medical Center, San Franc... More >>isco, California, 94143, United States|Children's National Hospital, Washington, District of Columbia, 20010, United States|University of Rochester, Rochester, New York, 14642, United States|Cook Children's Medical Center, Fort Worth, Texas, 76104, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.17mL

0.43mL

0.22mL

10.86mL

2.17mL

1.09mL

21.71mL

4.34mL

2.17mL

 

Historical Records

Categories